Company Profile

Znomics Inc
Profile last edited on: 2/17/2021      CAGE: 47EY3      UEI: QLJTULVM7NV6

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2001
First Award
2003
Latest Award
2006
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2611 Sw 3rd Avenue Suite 200
Portland, OR 97201
   (503) 827-5271
   info@znomics.com
   www.znomics.com
Location: Single
Congr. District: 01
County: Multnomah

Public Profile

Founded by scientists from Oregon Health and Science University, the most recent data on Znomics indicates the firm was acquired in October 2-13 by Williston Holding Company, Inc., in a reverse merger transaction with the firm now operates as an infrastructure development company. Over the previous decade Znomics had been a drug discovery company working on the zebrafish (Danio rerio) as a system to identify genes underlying human disease and to identify small molecule drugs affecting disease states. In November 2007, the firm merged with Pacific Syndicated Resources, Inc. (OTCBB:PSRI) and renamed the combined company as Znomics, Inc. under the leadership of the former Znomics' directors and officers. Znomics went on to create a catalogued library of mutations in the zebrafish, called the ZeneMark Library with over 11,000 strains of fish representing approximately half of the known genes. Znomics identified mutations in 107 human disease genes with plans to use the library to find new drug targets and develop human disease models in the fish.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : PSRI
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2006 2 NIH $2,005,997
Project Title: Generation of a zebrafish insertional mutation Library

Key People / Management

  Richard Sessions -- Former CEO

  Bruce A Buetel -- CSO

  Gregory P Golling